Mode
Text Size
Log in / Sign up
N/A Completed N=451 Randomized Double-blind Treatment

Group-based Mindfulness for Chronic Pain in the Primary Care Setting

Postoperative Pain · Back Pain
Source: ClinicalTrials.gov NCT04129450 ↗
Enrolled (actual)
451
Serious AEs
0.0%
Results posted
Dec 2025
Primary outcomePrimary: Pain Intensity and Interference at Baseline, 8 Weeks, 6 Months (Primary Timepoint), & 12 Months: Pain, Enjoyment, General Activity (PEG) Score — 6.37; 5.87; 5.21; 5.6 score on a scale

Summary

The purpose of this pragmatic clinical trial (PCT) research is to determine whether a group-visit approach modeled on Mindfulness-Based Stress Reduction can improve function for persons with chronic low back pain. This will be done by an embedded PCT within the evidence-based "OPTIMUM" (Optimizing Pain Treatment In Medical settings Using Mindfulness) program.

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain Intensity and Interference at Baseline, 8 Weeks, 6 Months (Primary Timepoint), & 12 Months: Pain, Enjoyment, General Activity (PEG) Score
6.37; 5.87; 5.21; 5.6; 5.16; 5.28
SECONDARY
Physical Function at Baseline, 8 Weeks, 6 Months, and 12 Months
37.9; 37.9; 38; 37.9; 39.4; 38
SECONDARY
Sleep Disturbance at Baseline, 8 Weeks, 6 Months, & 12 Months
57.5; 56.4; 54.9; 55.6; 55.8; 55.9
SECONDARY
Opioid Prescription Use at Baseline, 8 Weeks, 6 Months, and 12 Months
7.3; 8.4; 7.9; 8.2; 8.3; 9.8
SECONDARY
Mindfulness at Baseline, 8 Weeks, 6 Months, & 12 Months
33.2; 32.7; 33.8; 33; 33.3; 33.3
SECONDARY
Mindfulness at 12 Months
49.7; 47.9
SECONDARY
Patient Impression of Change at 8 Weeks, 6 Months, & 12 Months
10; 3; 42; 7; 74; 40
SECONDARY
Pain Catastrophizing at Baseline, 8 Weeks, 6 Months, & 12 Months
12.5; 11.8; 10.9; 10.9; 10.5; 10.6
SECONDARY
Tobacco, Alcohol, Prescription Medications, and Other Substance Use at Baseline and 12 Months
80; 98; 144; 129; 78; 101
SECONDARY
Comorbidity at Baseline
2.4; 2.3
SECONDARY
Anxiety at Baseline, 6 Months, & 12 Months
80; 98; 144; 129; 26; 29
SECONDARY
Depression at Baseline, 6 Months, & 12 Months
167; 166; 57; 61; 27; 27
SECONDARY
Sleep Duration at Baseline and 6 Months
5.6; 5.8; 5.9; 5.6

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18
  • Chronic low back pain, which is pain that persists for at least 3-months and has resulted in pain on at least half the days in the past 6 months
  • A score ≥ 3 on the Pain, Enjoyment of Life and General Activity (PEG)
  • Willing and able to provide online or telephone informed consent
  • Speak English as the intervention manual is currently written in English

Exclusion Criteria

  • Do not meet the above inclusion criteria
  • Red flags- recent (past month) worsening of pain, unexplained fever, unexplained weight loss
  • Pregnancy
  • Metastatic cancer
  • First-degree relatives (parents, siblings, child) of someone who has participated or is participating in the OPTIMUM study
  • Members of the same household
  • Not a patient at a participating clinic or persons not planning to continue as a patient at a participating clinic for 12 or more months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04129450). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search